AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
NASDAQ:ANGO
Price:
6.05 USD
-1.14%
Market Closed
Updated:
May 13, 2024
AngioDynamics Inc
Research & Development
|
AngioDynamics Inc
Research & Development Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Research & Development
-$32.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$1.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-20%
|
See Also
What is AngioDynamics Inc's Research & Development?
Research & Development
-32.6m
USD
-32.6m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Research & Development amounts to -32.6m USD.
What is AngioDynamics Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-2%
-2%
Over the last year, the Research & Development growth was -9%. The average annual Research & Development growth rates for AngioDynamics Inc have been 2% over the past three years , -4% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
